Quantitative
electroencephalograms may predict success of antidepressant therapy
Changes in frontal cortex activity detected with quantitative electroencephalography
can predict the effectiveness of an antidepressant medication within
days of initiation of treatment and weeks before there is a clinical
response, according to an article in the July issue Neuropsychopharmacology.
The new findings could lead to treatment programs that help patients
with depression feel better more quickly by decreasing the evaluation
period from weeks to days.
"Up to 40 percent of depressed
patients do not respond to the first medication they try. Since
it takes several weeks for an effective treatment to produce clear
improvement, doctors often wait 6 to 12 weeks to decide that a particular
medication just isn't right for that patient and move on to another
treatment," said Dr. Ian A. Cook, lead author of the study.
"By comparing electroencephalogram
(EEG) measurements before treatment with those soon after treatment
begins, doctors may be able to evaluate the usefulness of an antidepressant
within days rather than having to wait weeks-to-months," Cook
said. "This technique also could slash the time and costs needed
to develop and research new antidepressants."
The study examined 51 adult
patients diagnosed with acute depression. Each participated in one
of two double-blind, randomized treatment trials. One group received
fluoxetine or placebo. The other received venlafaxine or placebo.
Each subject received a quantitative electroencephalogram prior
to initiation of treatment, 48 hours after treatment, and one week
after treatment.
Of the 25 subjects given active
medication, 13 (52 percent) responded positively. Of the 26 subjects
given placebo, 10 (38 percent) responded. Subjects who responded
to medication uniquely showed significant decreases in cordance,
a measure of brain wave activity, at 48 hours and one week. Clinical
changes did not begin to emerge until after four weeks. Subjects
with the greatest measured changes in cordance had the most complete
response to the medication after eight weeks.
"Other researchers have
compared brain scans of depressed people before and after treatment
and found differences between those who recovered and those who
did not respond. Those findings, however, do not allow prediction
of whether a particular patient is likely to get well," said
Cook. "This is the first study to detect specific changes in
brain wave activity that precede the clinical changes in a way that
can usefully predict response."
Current research is aimed toward
determining whether the same pattern holds for other antidepressant
medications; the investigators are also working to simplify the
method to make it easier to use in the clinical setting.
|